HBK Investments’s St Jude Medical STJ Stock Holding History

HBK Investments’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,997,412	Closed	-$401M	–	903
2016 Q4	$401M	Buy	4,997,412 +3,239,535	+184%	+$257M	3.88%	5
2016 Q3	$140M	Buy	1,757,877 +954,371	+119%	+$77M	1.27%	9
2016 Q2	$62.7M	Buy	803,506 +770,530	+2,337%	+$54.9M	0.46%	20
2016 Q1	$1.81M	Sell	32,976 -26,724	-45%	-$1.46M	0.02%	454
2015 Q4	$3.69M	Buy	+59,700	New	+$3.77M	0.03%	280
2015 Q3	–	Sell	-3,300	Closed	-$241K	–	1203
2015 Q2	$241K	Buy	+3,300	New	+$238K	﹤0.01%	860
2014 Q4	–	Sell	-6,300	Closed	-$379K	–	1211
2014 Q3	$379K	Buy	+6,300	New	+$412K	0.01%	788

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

HBK Investments's STJ Position: Q1 2017 in Review

HBK Investments sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 4,997,412 shares — an estimated $401M sold.

HBK Investments first reported a position in STJ in Q3 2014 and held it in 7 quarters. The position peaked at $401M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

HBK Investments reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
HBK Investments sold 4,997,412 St Jude Medical shares in Q1 2017, an estimated $401M.
HBK Investments first reported a position in St Jude Medical in Q3 2014 and held it in 7 quarters.
HBK Investments's St Jude Medical position peaked at $401M in Q4 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on HBK Investments's 13F filing for Q1 2017, filed 15 May 2017.